FDA.reportPublic FDA data

Pradaxa 150 MG (as dabigatran etexilate mesylate 172.95 MG) Oral Capsule

RxCUI
1037049
RxNorm name
Pradaxa 150 MG (as dabigatran etexilate mesylate 172.95 MG) Oral Capsule
Display name
Pradaxa 150 MG (as dabigatran etexilate mesylate 172.95 MG) Oral Capsule
Full name
Pradaxa 150 MG (as dabigatran etexilate mesylate 172.95 MG) Oral Capsule
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:18

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
PradaxaDABIGATRAN ETEXILATE MESYLATEBoehringer Ingelheim Pharmaceuticals Inc.ba74e3cd-b06f-4145-b284-5fd6b84ff3c92025-06-25Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1037049

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
ba74e3cd-b06f-4145-b284-5fd6b84ff3c9Pradaxa 150 MG (as dabigatran etexilate mesylate 172.95 MG) Oral CapsuleSY48These highlights do not include all the information needed to use PRADAXA Capsules safely and effectively. See full prescribing information for PRADAXA Capsules. PRADAXA ® (dabigatran etexilate) capsules, for oral use Initial U.S. Approval: 201020250625
ba74e3cd-b06f-4145-b284-5fd6b84ff3c9Pradaxa 150 MG Oral CapsuleSY48These highlights do not include all the information needed to use PRADAXA Capsules safely and effectively. See full prescribing information for PRADAXA Capsules. PRADAXA ® (dabigatran etexilate) capsules, for oral use Initial U.S. Approval: 201020250625
ba74e3cd-b06f-4145-b284-5fd6b84ff3c9dabigatran etexilate 150 MG Oral Capsule [Pradaxa]SBD48These highlights do not include all the information needed to use PRADAXA Capsules safely and effectively. See full prescribing information for PRADAXA Capsules. PRADAXA ® (dabigatran etexilate) capsules, for oral use Initial U.S. Approval: 201020250625
ba74e3cd-b06f-4145-b284-5fd6b84ff3c9Pradaxa 150 MG Oral CapsulePSN48These highlights do not include all the information needed to use PRADAXA Capsules safely and effectively. See full prescribing information for PRADAXA Capsules. PRADAXA ® (dabigatran etexilate) capsules, for oral use Initial U.S. Approval: 201020250625
80637981-d5a7-48cb-b7b2-f50807a8ab20Pradaxa 150 MG Oral CapsulePSN8These highlights do not include all the information needed to use PRADAXA safely and effectively. See full prescribing information for PRADAXA. PRADAXA® (dabigatran etexilate) capsules, for oral use Initial U.S. Approval: 201020210616
80637981-d5a7-48cb-b7b2-f50807a8ab20dabigatran etexilate 150 MG Oral Capsule [Pradaxa]SBD8These highlights do not include all the information needed to use PRADAXA safely and effectively. See full prescribing information for PRADAXA. PRADAXA® (dabigatran etexilate) capsules, for oral use Initial U.S. Approval: 201020210616
80637981-d5a7-48cb-b7b2-f50807a8ab20Pradaxa 150 MG Oral CapsuleSY8These highlights do not include all the information needed to use PRADAXA safely and effectively. See full prescribing information for PRADAXA. PRADAXA® (dabigatran etexilate) capsules, for oral use Initial U.S. Approval: 201020210616
80637981-d5a7-48cb-b7b2-f50807a8ab20Pradaxa 150 MG (as dabigatran etexilate mesylate 172.95 MG) Oral CapsuleSY8These highlights do not include all the information needed to use PRADAXA safely and effectively. See full prescribing information for PRADAXA. PRADAXA® (dabigatran etexilate) capsules, for oral use Initial U.S. Approval: 201020210616
5db7f199-8752-4d24-85f7-e34ca8f4d02ePradaxa 150 MG Oral CapsuleSY1These highlights do not include all the information needed to use PRADAXA safely and effectively. See full prescribing information for PRADAXA. PRADAXA® (dabigatran etexilate mesylate) capsules for oral use Initial U.S. Approval: 201020101123
5db7f199-8752-4d24-85f7-e34ca8f4d02ePradaxa 150 MG Oral CapsulePSN1These highlights do not include all the information needed to use PRADAXA safely and effectively. See full prescribing information for PRADAXA. PRADAXA® (dabigatran etexilate mesylate) capsules for oral use Initial U.S. Approval: 201020101123
5db7f199-8752-4d24-85f7-e34ca8f4d02ePradaxa 150 MG (as dabigatran etexilate mesylate 172.95 MG) Oral CapsuleSY1These highlights do not include all the information needed to use PRADAXA safely and effectively. See full prescribing information for PRADAXA. PRADAXA® (dabigatran etexilate mesylate) capsules for oral use Initial U.S. Approval: 201020101123
5db7f199-8752-4d24-85f7-e34ca8f4d02edabigatran etexilate 150 MG Oral Capsule [Pradaxa]SBD1These highlights do not include all the information needed to use PRADAXA safely and effectively. See full prescribing information for PRADAXA. PRADAXA® (dabigatran etexilate mesylate) capsules for oral use Initial U.S. Approval: 201020101123